Article
ADAM17 transactivates EGFR signaling during embryonic eyelid closure.
Investigative ophthalmology & visual science - 7 Jan 2013
Hassemer Eryn L, Endres Bradley, Toonen Joseph A, Ronchetti Adam, Dubielzig Richard, Sidjanin Duska J
Abstract excerpt
PURPOSE: During mammalian embryonic eyelid closure ADAM17 has been proposed to play a role as a transactivator of epidermal growth factor receptor (EGFR) signaling by shedding membrane bound EGFR ligands. However, ADAM17 also sheds numerous other ligands, thus implicating ADAM17 in additional molecular pathways. The goal of this study was to experimentally establish the role of ADAM17 and determine...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
